Ask a Fool: What's Your Take on Alcatel-Lucent?

Before you go, we thought you'd like these...
Before you go close icon

Several months after teetering on what seemed like the brink of bankruptcy, shares of Alcatel-Lucent have recovered nicely from their sub-$1 lows. And while much has improved for the struggling telecom equipment giant, it's by no means out of the woods. The company still faces plenty of risk as it attempts to further execute on its long-term restructuring efforts. Given so many moving parts, what's the bottom line? In this edition of our Ask a Fool series, Fool contributor Andrew Tonner give his take on Alcatel and how investors should play this recovery story.

A fresh idea for 2013
Want to get in on the smartphone phenomenon? Truth be told, one company sits at the crossroads of smartphone technology as we know it. It's not your typical household name, either. In fact, you've probably never even heard of it! But it stands to reap massive profits NO MATTER WHO ultimately wins the smartphone war. To find out what it is, click here to access The Motley Fool's latest free report: "One Stock You Must Buy Before the iPhone-Android War Escalates Any Further..."

The article Ask a Fool: What's Your Take on Alcatel-Lucent? originally appeared on

Fool contributor Andrew Tonner has no position in any stocks mentioned. Follow Andrew and all his writing on Twitter at @AndrewTonnerThe Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading